About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01503567

Epidemiological Study on Haemophilia Care and Orthopaedic Status in Developing Countries

This study is conducted in Africa and Asia. The aim of this study is to evaluate in the participating countries the orthopaedic status and the degree of arthropathy of severe haemophilia patients in g...

Lead sponsor: Novo Nordisk A/S•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Sponsors

Lead Sponsor

Novo Nordisk A/S

Age

6 - 18 years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Patient (and/or parents or the patient's legally acceptable representative, if applicable) must give signed and dated informed consent before enrolment in the study
•Male patients at least 6 years old with diagnosis of severe congenital haemophilia A or B with or without inhibitors
•Patients receiving on demand replacement factors/bypassing agents therapy

Exclusion Criteria

•Clinically relevant coagulation disorders other than congenital haemophilia A or B
•Patients on currently active treatment for HCV (Hepatitis C Virus) or HIV (Human Immune Deficiency Virus) infections

Related studies

RECRUITINGPhase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814 · Haemophilia A (Moderate or Severe)

Prevalence of Synovitis in Patients With Haemophilia A

NCT06352216 · Haemophilia A, Synovitis, and more

Enrolling By Invitation

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

NCT06285071 · Haemophilia A, Haemophilia B

Enrolling By Invitation

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

NCT06831734 · Haemophilia A, Haemophilia B

Active Not RecruitingPhase 4

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

NCT06752850 · Haemophilia A (Moderate or Severe), Hemophilia, Classic, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 18, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment282

Start dateJan 2012

Last updatedJan 18, 2017

Condition

Congenital Bleeding Disorder Haemophilia A Haemophilia A With Inhibitors Haemophilia B Haemophilia B With Inhibitors

Locations shown

Novo Nordisk Investigational Site

Bangalore

Novo Nordisk Investigational Site

Casablanca

Novo Nordisk Investigational Site

Muscat

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 18, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions